Raia Drogasil (OTCMKTS:RADLY) Trading Down 6.1%

Raia Drogasil S.A. (OTCMKTS:RADLY) shares were down 6.1% during mid-day trading on Wednesday . The stock traded as low as $5.04 and last traded at $5.09. Approximately 770 shares were traded during mid-day trading, a decline of 85% from the average daily volume of 5,302 shares. The stock had previously closed at $5.42.

The business’s 50 day moving average is $5.15.

About Raia Drogasil (OTCMKTS:RADLY)

Raia Drogasil SA engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. As of September 30, 2020, the company operated a network of 2,223 drug stores in 23 Brazilian states. It also markets its goods through telesales and its three call centers in the states of São Paulo and Tocantins.

Read More: What is Depreciation?

Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.

Raia Drogasil (OTCMKTS:RADLY) Trading Down 6.1%

Raia Drogasil S.A. (OTCMKTS:RADLY) shares were down 6.1% during mid-day trading on Wednesday . The stock traded as low as $5.04 and last traded at $5.09. Approximately 770 shares were traded during mid-day trading, a decline of 85% from the average daily volume of 5,302 shares. The stock had previously closed at $5.42.

The business’s 50 day moving average is $5.15.

About Raia Drogasil (OTCMKTS:RADLY)

Raia Drogasil SA engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. As of September 30, 2020, the company operated a network of 2,223 drug stores in 23 Brazilian states. It also markets its goods through telesales and its three call centers in the states of São Paulo and Tocantins.

Read More: What is Depreciation?

Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.